GlassScriptPhysician profile
Kazuo Suzuki
NPI 1841356888
$57,089.56
in general payments reported to CMS, 2019-2025
40 companies · $28K in 2025
The $28K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $684 · 2020: $471 · 2021: $174 · 2022: $7,288 · 2023: $6,754 · 2024: $14K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Food and Beverage: $3,162 · Honoraria: $3,000 · Travel and Lodging: $1,633 · Entertainment: $303 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,245.00 |
| Food and Beverage | $3,162.13 |
| Honoraria | $3,000.00 |
| Travel and Lodging | $1,633.41 |
| Entertainment | $303.19 |
| Education | $129.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $20,610.87 | 2024-2025 | Recell, Permeaderm, Cohealyx |
| Kaneka Medical America LLC | $17,903.19 | 2024-2025 | Apheresis Machine |
| Daiichi Sankyo INC. | $12,500.00 | 2022-2023 | |
| Novo Nordisk INC | $1,896.76 | 2023-2025 | Victoza, Ozempic, Wegovy |
| Paratek Pharmaceuticals, INC. | $878.28 | 2020-2025 | Nuzyra |
| Smith+Nephew, INC. | $396.40 | 2019-2021 | |
| Amgen INC. | $270.41 | 2019-2025 | Krystexxa |
| Medtronic, INC. | $256.36 | 2022 | |
| Allergan, INC. | $243.38 | 2019-2020 | |
| Mimedx Group, INC. | $221.39 | 2024 | |
| Polynovo North America LLC | $187.25 | 2024-2025 | Novosorb Btm |
| Kerecis Limited | $164.28 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Angiodynamics, INC. | $156.32 | 2022 | |
| Aroa Biosurgery Incorporated | $125.75 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $124.27 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $123.96 | 2019-2024 | Puraply |
| Arcutis Biotherapeutics, INC. | $121.69 | 2023 | |
| Urgo Medical North America, LLC | $101.07 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Integra Lifesciences Corporation | $78.60 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Horizon Therapeutics Plc | $66.59 | 2023 | Krystexxa |
| Janssen Pharmaceuticals, INC | $66.15 | 2019-2024 | Xarelto |
| Biotissue Holdings INC. | $53.22 | 2021 | |
| Amniox Medical, INC. | $51.78 | 2020 | |
| Stryker Corporation | $51.05 | 2025 | Sonopet Iq |
| Acell, INC. | $47.20 | 2019-2020 | |
| Tactile Systems Technology INC | $37.58 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Janssen Scientific Affairs, LLC | $34.77 | 2023 | Xarelto |
| Sientra, INC. | $33.72 | 2021 | |
| Hartmann USA, INC. | $33.05 | 2022-2024 | Zetuvit Plus 10x10 P10 |
| Resmed Corp | $31.67 | 2023 | |
| Merck Sharp & Dohme LLC | $28.12 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.62 | 2020 | |
| Convatec INC. | $25.74 | 2020-2021 | |
| Next Science LLC | $24.89 | 2023 | Surgx, Blastx, Xperience |
| Melinta Therapeutics, LLC | $23.54 | 2021-2022 | |
| Abbvie INC. | $23.47 | 2022 | |
| Checkpoint Surgical, INC | $20.77 | 2023 | Checkpoint Stimulators |
| Pfizer INC. | $19.67 | 2019 | |
| Tela Bio, INC. | $19.39 | 2024 | Ovitex 2s |
| Musculoskeletal Transplant Foundation INC. | $9.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kazuo Suzuki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.